Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases | NEJM
Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limit…